This review and meta-analysis aim to address this gap in knowledge by systematically analyzing the available evidence on the associations between four IGF1 pathway gene (IGF1, IGF1R, IRS1, and IRS2) polymorphisms and CRC risk. Here, IRS2 is linked to colorectal carcinoma.